Correction: Jannoo et al. Targeting and Sensitization of Breast Cancer Cells to Killing with a Novel Interleukin-13 Receptor α2-Specific Hybrid Cytolytic Peptide. Cancers 2023, 15, 2772
Riaz Jannoo, William Walker, Venkateswarlu Kanamarlapudi
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAntimicrobial Peptides and Activities · Immunotherapy and Immune Responses · RNA Interference and Gene Delivery
In the original publication [1], there was a mistake in Figures 4 and 9 and reference [43] when published. The headers for the top two tables were inaccurate in Figure 4b. Incorrect images were used for MCF-10A (untreated), MCF-7 (Phor21) and MDA-MB-231 (Phor21) in Figure 9. The corrected Figure 4 and Figure 9 and Reference [43] appears below.
Reference [43]: Gkretsi, V.; Stylianou, A.; Louca, M.; Stylianopoulos T. Identification of Ras suppressor-1 (RSU-1) as a potential breast cancer metastasis biomarker using a three-dimensional in vitro approach. Oncotarget 2017, 8, 27364–27379. https://doi.org/10.18632/oncotarget.16062.
The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
The reference list from the paper itself. Each links out to its DOI / PubMed record.